ArticleFrontiers in pharmacology2024

Stigmasterol mitigates estrogen-deficiency-induced osteoporosis through inhibition of phosphorylated p65 and MAPK signaling pathways.

Qiangqiang Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.